Overview
Well-known and respected in the Broward County community, Board-Certified Radiation Oncologist Dr. Marshal Lieberfarb trained at Harvard School of Medicine and Brigham Women’s Hospital/Dana Farber Cancer Institute in Boston, MA. With decades of expertise in the latest radiation therapy technologies for optimal patient outcomes, Dr. Lieberfarb treats patients with a variety of cancers, including breast, lung, gynecologic and gastrointestinal malignancies.
Dr. Lieberfarb has written and published numerous medical oncology and basic science articles in well-recognized, peer-reviewed journals. Examples of Dr. Lieberfarb’s medical research include a genetic analysis of prostate cancer as well as several clinical contributions to the medical management of prostate cancer.
Nominated by his peers over numerous consecutive years, Dr. Lieberfarb has been named to various Top Doctors lists for providing high-quality and compassionate care. He also served as Medical Director at Broward Health hospitals for more than a decade.
.svg){kind=icon}
Career positions
- GenesisCare - Medical Director, Southeast Florida, Pembroke Pines, FL
- GenesisCare - Radiation Oncologist, Fort Lauderdale, FL
- Aventura Medical Center - Clinical Radiation Oncologist, Aventura, FL
- Holy Cross Hospital - Clinical Radiation Oncologist, Fort Lauderdale, FL
Education
Universities
- Massachusetts Institute of Technology, BS, Biology, Cambridge, MA
- University of Stony Brook Graduate School of Pharmacology & School of Medicine, Doctor of Medicine, Stony Brook, NY
Residency
- Harvard Joint Center for Radiation Therapy, Radiation Oncology, Boston, MA
Internship
- Harvard Medical School, Mt. Auburn Hospital, Internal Medicine, Cambridge, MA
Professional association
Awards and honors
- Alpha Omega Alpha Medical Honor Society
- Marvin Kuschner Award for Overall Excellence in Medical School
Publications
- Simultaneous Integrated Boost (SIB) for Advanced Head and Neck (H&N) Cancer May Accelerate Muscle Loss in Concurrent Chemoradiation as Assessed by a Validated CT-Based Tool
- Multicenter Assessment of Stereotactic Body Radiation Therapy (SBRT) Boost in Intermediate-Risk Prostate Cancer: Biochemical Failure and Toxicity